Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Published:2020-09-21 Issue:22 Volume:9 Page:8318-8332
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Rao Qian‐Wen¹²,Zhang Shi‐Long³^ORCID,Guo Meng‐Zhou²,Yuan Fei‐Fei²,Sun Jia‐Lei²,Qi Feng²,Wang Li‐Shun³,Yang Bi‐Wei²,Xia Jing‐Lin¹²^ORCID

Affiliation:

1. Minhang Branch Zhongshan Hospital Fudan University Shanghai China

2. Liver Cancer Institute Zhongshan Hospital Fudan University Shanghai China

3. Institute of Fudan‐Minhang Academic Health System Minhang Branch Zhongshan Hospital Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3430

Reference46 articles.

1. Hepatocellular carcinoma: clinical frontiers and perspectives

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Hepatocellular carcinoma

4. Alpha‐fetoprotein in acute viral hepatitis;Akeyama T;N Engl J Med,1972

5. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulfiredoxin-1 promotes the growth of hepatocellular carcinoma by inhibiting TFEB-mediated autophagy and lysosome biogenesis;Experimental Cell Research;2024-08

2. A refined therapeutic plan based on the machine-learning prognostic model of liver hepatocellular carcinoma;Computers in Biology and Medicine;2024-02

3. Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors;Biochimica et Biophysica Acta (BBA) - General Subjects;2023-10

4. Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer;BMC Urology;2023-09-19

5. Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model;Frontiers in Oncology;2023-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3